Striving towards better health and a brighter future for people through leading innovation in medicines involve risks and Takeda is exposed to various risks and uncertainty including in research and development, intellectual property rights, decline of sales due expiration of patents, drop in prices due to price pressure and healthcare reforms in major markets, fluctuation of foreign exchange rates, corporate acquisitions, stable supply, litigation, and IT security and information control.